http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002187959-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-729 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-732 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2002-07-22^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97dcda54fd89828726314e01dd5c5ee0 |
| publicationDate | 2002-12-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002187959-A1 |
| titleOfInvention | Compositions and methods for treating mammals with modified alginates and modified pectins |
| abstract | A modified alginate and/or modified pectin composition and method for preventing and/or treating diseases and/or conditions caused by circulating agents such as poisonous heavy metals, environmental toxins, calcium and cholesterol, is provided. The composition includes a modified alginate having a molecular weight of no more than 40,000 daltons and/or a modified pectin having a molecular weight of no more than 40,000 daltons. The method involves orally or intravenously administering the modified alginate and/or modified pectin composition, alone or with excipient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906499-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006172986-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011124234-A1 |
| priorityDate | 1999-02-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 55 of 55.